ONCASPAR (pegaspargase)

ONCASPAR (pegaspargase)About

Verify this business
4.1 10 Reviews
www.oncaspar.com
Write a review
Reviews10NewsPhotosWidgetsDetails

About company

NCASPAR (pegaspargase) is indicated as a component of a multi-agent chemotherapeutic regimen for the first–line treatment of patients with acute lymphoblastic leukemia (ALL) and for the treatment of patients with ALL and hypersensitivity to native forms of L-asparaginase.